Kedrion Biopharma Announces the Extension of a U.S. Agreement with Grifols to Support Long-Term and Continued Access to GAMMAKED®
Latest PR Newswire FDA coverage of Kedrion Biopharma Announces the Extension of a U.S. Agreement with Grifols to Su
Kedrion Biopharma
Private
Global biopharmaceutical company specializing in plasma-derived products for rare and serious diseases.
Company Info
Sector:Biologics / Plasma-Derived Therapies
Headquarters:Castelvecchio Pascoli, Italy
Founded:2001
Website:www.kedrion.us/